Forbes August 20, 2025
With 250 biomarkers and $29M raised, Kean wants to prove predictive health isn’t a gimmick — it’s infrastructure.
When ‘Healthy’ Isn’t: The Case That Redefines Prevention
A 60-year-old woman walked into her doctor’s office feeling perfectly healthy. She exercised, ate well, and had no family history of serious disease. But her physician had ordered a new kind of test — a multi-omic blood panel from Vancouver-based Molecular You. The results flagged early molecular signals pointing to pancreatic cancer, one of the deadliest diseases in medicine and almost always diagnosed too late. For her, the promise of predictive health became real: the disease was caught before symptoms appeared, treatment was swift, and survival odds dramatically improved.
Early detection didn’t just save...
Today's Sponsors
Today's Sponsor